Welcure Drugs & Pharmaceuticals Ltd. | Small-cap | Healthcare
₹11.92
-4.94%
| Welcure Drugs Stock Comparison:
Welcure Drugs vs Sun PharmaceuticalWelcure Drugs vs Divi's LaboratoriesWelcure Drugs vs Sun Pharma AdvancedWelcure Drugs vs Sequent ScientificWelcure Drugs vs Gujarat ThemisWelcure Drugs vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 3.0B
Gross Profit 312.0M 10.40%
Operating Income 311.4M 10.38%
Net Income 233.0M 7.77%
EPS (Diluted) ₹2.07

Balance Sheet Metrics

Total Assets 2.7B
Total Liabilities 1.6B
Shareholders Equity 1.0B
Debt to Equity 1.60

Cash Flow Metrics

Revenue & Profitability Trend

Welcure Drugs Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i245.5M001.0M1.3M
Cost of Goods Sold i205.0M0000
Gross Profit i40.5M0000
Gross Margin % i16.5%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i-473.0K293.0K160.9K154.6K
Other Operating Expenses i28.9M670.0K606.0K500.2K525.3K
Total Operating Expenses i28.9M1.1M899.0K661.1K679.8K
Operating Income i8.7M-2.7M-1.4M236.5K550.2K
Operating Margin % i3.5%0.0%0.0%22.5%41.3%
Non-Operating Items
Interest Income i-579.0K444.0K02.2K
Interest Expense i00000
Other Non-Operating Income-----
Pre-tax Income i27.8M-1.7M1.0M235.8K551.5K
Income Tax i6.1M0000
Effective Tax Rate % i21.9%0.0%0.0%0.0%0.0%
Net Income i21.7M-1.7M1.0M235.8K551.5K
Net Margin % i8.8%0.0%0.0%22.5%41.4%
Key Metrics
EBITDA i27.9M-1.4M-878.0K236.5K550.2K
EPS (Basic) i₹0.36₹-0.13₹0.08₹0.02₹0.05
EPS (Diluted) i₹0.36₹-0.13₹0.08₹0.02₹0.05
Basic Shares Outstanding i11251210013512000134390001211855812118558
Diluted Shares Outstanding i11251210013512000134390001211855812118558

Income Statement Trend

Welcure Drugs Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i1.3M216.0K12.0K660.1K474.6K
Short-term Investments i195.1M----
Accounts Receivable i189.5M0-00
Inventory i1.4B0--0
Other Current Assets308.0K102.0K---
Total Current Assets i1.8B318.0K59.0K660.1K474.6K
Non-Current Assets
Property, Plant & Equipment i-209.0K---
Goodwill i-0-00
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets773.0K1.0K-308.0K-
Total Non-Current Assets i848.4M13.4M15.2M308.1K255.6K
Total Assets i2.7B13.7M15.3M968.2K730.2K
Liabilities
Current Liabilities
Accounts Payable i29.0M0000
Short-term Debt i-0000
Current Portion of Long-term Debt-----
Other Current Liabilities168.0K105.0K---
Total Current Liabilities i412.7M306.0K136.0K38.2K35.9K
Non-Current Liabilities
Long-term Debt i1.2B-0-0
Deferred Tax Liabilities i-0000
Other Non-Current Liabilities-----
Total Non-Current Liabilities i1.2B0000
Total Liabilities i1.6B306.0K136.0K38.2K35.9K
Equity
Common Stock i1.1B134.4M134.4M121.2M121.2M
Retained Earnings i--122.5M-120.7M-121.8M-122.0M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.0B13.4M15.2M930.0K694.2K
Key Metrics
Total Debt i1.2B0000
Working Capital i1.4B12.0K-77.0K622.0K438.7K

Balance Sheet Composition

Welcure Drugs Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i27.8M-1.7M1.0M235.8K551.5K
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-2.3B114.0K51.0K-50.3K-129.6K
Operating Cash Flow i-2.2B-1.6M1.1M185.5K421.9K
Investing Activities
Capital Expenditures i-170.0K----
Acquisitions i-----
Investment Purchases i-----
Investment Sales i-1.6M0--
Investing Cash Flow i-635.0K1.6M0--
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i1.2B----
Debt Repayment i--171.0K-14.9M--
Financing Cash Flow i2.2B-171.0K-1.7M--
Free Cash Flow i-2.2B-1.3M1.1M185.5K421.9K
Net Change in Cash i-28.0M-155.0K-649.0K185.5K421.9K

Cash Flow Trend

Welcure Drugs Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 4.43
Price to Book 0.89
Price to Sales 0.41
PEG Ratio 0.00

Profitability Ratios

Profit Margin 7.96%
Operating Margin 10.38%
Return on Equity 2.12%
Return on Assets 0.81%

Financial Health

Current Ratio 4.41
Debt to Equity 120.18
Beta -1.76

Per Share Data

EPS (TTM) ₹2.69
Book Value per Share ₹13.32
Revenue per Share ₹38.13

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
welcure1.3B4.430.892.12%7.96%120.18
Sun Pharmaceutical 3.9T38.005.4715.08%19.29%3.26
Divi's Laboratories 1.6T70.8710.9114.64%23.89%0.03
Sun Pharma Advanced 47.4B-13.85-21.83157.88%-53.22%-1.24
Sequent Scientific 44.4B155.796.302.84%1.85%62.47
Gujarat Themis 43.3B96.8917.3919.64%30.17%12.27

Financial data is updated regularly. All figures are in the company's reporting currency.